Announcements Trials
Browse Landscape

Phase

Phase 3 17Phase 4 14Phase NA 8Phase 2 5Phase 1/2 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Pelvic Mass 1

Interventions

Magnetic Resonance Spectroscopy 61Cyclophosphamide 57pembrolizumab 39fludarabine 38Radiotherapy 30Nivolumab 30Biopsy 27Metformin 23Fluorodeoxyglucose F18 22Bevacizumab 22Specimen Handling 21Temozolomide 18Cisplatin 18Radiosurgery 17Carboplatin 16Fluorouracil 15Paclitaxel 14Dexamethasone 14Radiation 13Gemcitabine 13Etoposide 13Rituximab 12Positron Emission Tomography Computed Tomography 12Letrozole 12Irinotecan 12gallium 68 PSMA-11 11durvalumab 11atezolizumab 11X-Rays 11Surgical Procedures, Operative 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Interventional × Tranexamic Acid × Clear all
NCT03128866 2026-03-05

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
80 enrolled

Pelvic Mass

NCT04630886 2024-11-19

Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery

University of Massachusetts, Worcester

Phase EARLY_PHASE1 Terminated
34 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡